Published online before print August 17, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
,1
* Institut Cochin, Département d'Immunologie, Paris, F-75014, France;
INSERM U567, Paris, F-75014, France;
CNRS, UMR-S 8104, Paris, F-75014, France; and
Université Paris 5, Faculté de Médecine René Descartes, UM3, Paris, F-75014, France
1 Correspondence: Institut Cochin, Département d'Immunologie, 27, rue du Fg St. Jacques, Bat Gustave Roussy 8eme etage, Paris 75014, France. E-mail: hosmalin{at}cochin.inserm.fr
Type I IFNs display multiple biological effects. They have a strong antiviral action, not only directly but also indirectly through activation of the immune system. They may also have actions that are deleterious for the host. The cells that produce type I IFN are mostly plasmacytoid dendritic cells (pDC), but this depends on the viral stimulus. The migration and distribution of pDC into lymphoid organs, driven by chemokine interactions with their ligands, determines interaction with different cell types. In HIV infection, IFN production in vitro is impaired during primary infection and later in association with opportunistic infections. Circulating pDC numbers are decreased in parallel. These parameters may be used to help assess the prognosis of the disease and to monitor treatment.
Key Words: plasmacytoid dendritic cells • innate immunity • adaptive immunity • immune therapy • vaccination • primary infection • virus
This article has been cited by other articles:
 |
|
 |
|
  J. Chehimi, E. Papasavvas, C. Tomescu, B. Gekonge, S. Abdulhaqq, A. Raymond, A. Hancock, K. Vinekar, C. Carty, G. Reynolds, et al. Inability of Plasmacytoid Dendritic Cells To Directly Lyse HIV-Infected Autologous CD4+ T Cells despite Induction of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand J. Virol., March 15, 2010; 84(6): 2762 - 2773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Vendrame, M. Sourisseau, V. Perrin, O. Schwartz, and F. Mammano Partial Inhibition of Human Immunodeficiency Virus Replication by Type I Interferons: Impact of Cell-to-Cell Viral Transfer J. Virol., October 15, 2009; 83(20): 10527 - 10537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Clerzius, J.-F. Gelinas, A. Daher, M. Bonnet, E. F. Meurs, and A. Gatignol ADAR1 Interacts with PKR during Human Immunodeficiency Virus Infection of Lymphocytes and Contributes to Viral Replication J. Virol., October 1, 2009; 83(19): 10119 - 10128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Hughes, B. Amadi, M. Mwiya, H. Nkamba, A. Tomkins, and D. Goldblatt Dendritic Cell Anergy Results from Endotoxemia in Severe Malnutrition J. Immunol., August 15, 2009; 183(4): 2818 - 2826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nascimbeni, L. Perie, L. Chorro, S. Diocou, L. Kreitmann, S. Louis, L. Garderet, B. Fabiani, A. Berger, J. Schmitz, et al. Plasmacytoid dendritic cells accumulate in spleens from chronically HIV-infected patients but barely participate in interferon-{alpha} expression Blood, June 11, 2009; 113(24): 6112 - 6119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Iannello, O. Debbeche, S. Samarani, and A. Ahmad Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination J. Leukoc. Biol., July 1, 2008; 84(1): 27 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Fiorentini, E. Riboldi, F. Facchetti, M. Avolio, M. Fabbri, G. Tosti, P. D. Becker, C. A. Guzman, S. Sozzani, and A. Caruso HIV-1 matrix protein p17 induces human plasmacytoid dendritic cells to acquire a migratory immature cell phenotype PNAS, March 11, 2008; 105(10): 3867 - 3872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Montaner, S. M. Crowe, S. Aquaro, C.-F. Perno, M. Stevenson, and R. G. Collman Advances in macrophage and dendritic cell biology in HIV-1 infection stress key understudied areas in infection, pathogenesis, and analysis of viral reservoirs J. Leukoc. Biol., November 1, 2006; 80(5): 961 - 964. [Abstract] [Full Text] [PDF]
|
|
